Dr. Lipscomb's numerous research grants include funding from the National Institutes of Health on reducing health care disparities in urban areas.
Titles and Roles
- Professor of Health Policy and Management
- Rollins School of Public Health, Emory University
- Research Program
- Cancer Prevention and Control
A Georgia Cancer Coalition Distinguished Cancer Scholar, Dr. Lipscomb is Professor of Health Policy and Management for the Rollins School of Public Health at Emory University. He served as Associate Director for Population Sciences at Winship Cancer Institute from 2010 until 2014.
Dr. Lipscomb was Chief of the Outcomes Research Branch at the National Cancer Institute from 1999 until arriving at Emory in 2004. While at the NCI, he co-chaired the Cancer Outcomes Measurement Working Group, chaired the trans-agency Quality of Cancer Care Committee, and was NCI lead for a collaborative effort with the National Quality Forum to develop consensus measures of cancer care quality.
He received his PhD in economics from the University of North Carolina at Chapel Hill in 1975, and a BA in mathematics from Vanderbilt University in 1970.
Dr. Lipscomb is principal investigator on two research grants from the Centers for Disease Control and Prevention, one examining optimal screening for those at elevated risk to breast and colorectal cancer and the other investigating the quality of cancer care for those diagnosed with breast or prostate cancer in Georgia. He is also principal investigator on a grant from the Association of Schools of Public Health and the CDC (funded by NCI and the Georgia Cancer Coalition) to augment the Georgia Comprehensive Cancer Registry with administrative and clinical data from multiple public and private sources to support quality-of-care assessment.
He has published widely on various topics in health economics and outcomes research, including on patient-reported outcomes assessment, quality-of-care evaluation and improvement, and the theory and practice of cost-effectiveness analysis. He was co-editor for the volume, Outcomes Assessment in Cancer: Measures, Methods, and Applications (Cambridge University Press, 2005); co-editor of a Journal of the National Cancer Institute Monograph (2004) on cancer outcomes research; co-editor for a special issue of Value in Health on, "Moving the QALY Forward: Building a Pragmatic Road" (2009); co-editor of a Medical Care supplement on, "Health Care Costing: Data, Methods, and Future Directions" (2009); and co-editor of Journal of the National Cancer Institute Monograph on "Combining Epidemiology and Economics for Measurement of Cancer Costs" now in preparation.